MENUNews Archive
Date: 03/01/2019
Researchers from the University of Michigan Rogel Cancer Center will attend the American Association for Cancer Research (AACR) Annual Meeting from Friday, March 29 through Wednesday, April 4, 2019. Many of them plan to participate in poster sessions and oral presentations. Below is a schedule of who is presenting, when, where and on what topic.
Date: 02/14/2019
Researchers from the Rogel Cancer Center have found that a genetic mutation seen in about half of all brain tumors produces a response that prevents radiation treatment from working. Altering that response using FDA-approved drugs restores tumors’ sensitivity to radiation therapy, extending survival in mice.
Date: 02/12/2019
Latest U.S. estimates indicate that since 1989, hundreds of thousands of women's lives have been saved by mammography and improvements in breast cancer treatment. The findings point to progress made in early detection and management of breast cancer.
Date: 02/04/2019
The stable structure of circRNA makes it an ideal candidate for biomarkers because it can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.
Date: 02/02/2019
University of Michigan researchers find infiltrating lymphocytes tie to survival in patients with recurrent larynx cancer; findings suggest super-boosting the immune system before additional treatment.
Date: 01/23/2019
Breast cancer survivors reported improvements in depression, pain, anxiety and sleep after self-administered acupressure.
Date: 01/04/2019
As genetic testing for breast cancer has become more complex, evaluating a panel of multiple genes, it introduces more uncertainty about the results. But a new study finds that newer, more extensive tests are not causing patients to worry more about their cancer risk.
Date: 12/18/2018
University of Michigan Rogel Cancer Center member Lori Pierce, M.D., was elected president of the American Society of Clinical Oncology.
Date: 12/05/2018
The University of Michigan research team retrospectively examined 485 women with autologous breast reconstructions (after mastectomies due to breast cancer) who underwent screening mammography over 15 years. The findings suggest that in addition to surveillance, breast cancer patients who undergo mastectomies and autologous tissue reconstruction may benefit from mammography screening of their flaps.
Date: 11/27/2018
Eric Fearon, M.D., Ph.D., was named a fellow of the American Association for the Advancement of Science, an honor bestowed upon AAAS members by their peers. Fearon is director of the University of Michigan Rogel Cancer Center and Emanuel N. Maisel Professor of Oncology. Several other Rogel Cancer Center members received this honor.